Camille MacMillin/STAT

STAT+ | Under a new leader, the FDA’s biologics center moves to steady itself after stormy chapter

After Vinay Prasad's turbulent tenure, acting director Karim Mikhail is working to restore staff morale and revisit controversial rare disease rejections.

By Lizzy Lawrence

Cassidy grills Trump nominee on past vaccine comments in heated exchange

Can a skeptic of the mRNA technology used against Covid lead the response to a new pandemic? Inside Sen. Bill Cassidy's clash with HHS nominee Sean Kaufman.

By Chelsea Cirruzzo and Helen Branswell

STAT+ | Medicare Advantage insurers face new bipartisan scrutiny over AI and care denials

Sens. Blumenthal and Hawley ask UnitedHealth Group, Humana, and CVS Health for documents related to using AI to deny or delay rehabilitative care.

By Casey Ross and Bob Herman

Adobe

Opinion: Why we still don’t know what foods are the source of the cyclospora outbreak

Washing lettuce isn't the lesson from this summer's cyclospora outbreak. The bigger story is why investigators still can't identify the contaminated food.

By Katrine Wallace

STAT+ | New study untangles how Epstein-Barr viral infection triggers immune response in multiple sclerosis

Researchers have uncovered how Epstein-Barr virus launches immune responses seen in people with multiple sclerosis, according to a new study. 

By Lauren Chan

Flood of comments on White House grantmaking overhaul is largely negative, analysis shows

Administration proposal to exert political control over science funding draws nearly 500,000 comments. Analysis finds 95% oppose OMB changes.

By Anil Oza and J. Emory Parker

Mwyngil

STAT+ | A new biotech startup tries to tackle obesity, but not in the way you might expect

The company, a collaboration between Torrey Pines Investments and a German research institution, is the rare drugmaker in the field forgoing GLP-1s.

By Allison DeAngelis

STAT+ | In a major policy shift, Medicare proposes to ban vendors from providing remote monitoring services

CMS wants to limit remote patient monitoring to clinical staff working for doctors. Vendor advocates say 'potentially cataclysmic' move threatens care.

By Mario Aguilar